41
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Anti-Leukemic and Anti-GVHD Effects of Campath-1H in Acute Lymphoblastic Leukemia Relapsed after Stem-Cell Transplantation

, , , , , , , , & show all
Pages 731-733 | Received 25 Jun 2003, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Runzhe Chen, Jos L Campbell & Baoan Chen. (2015) Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation. OncoTargets and Therapy 8, pages 405-412.
Read now
Pier Paolo Piccaluga, Mario Arpinati, Anna Candoni, Claudio Laterza, Stefania Paolini, Anna Gazzola, Elena Sabattini, Giuseppe Visani & Stefano A. Pileri. (2011) Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia. Leukemia & Lymphoma 52:2, pages 325-327.
Read now
Pier Paolo Piccaluga, Giovanni Martinelli & Michele Baccarani. (2006) Advances in the treatment for haematological malignancies. Expert Opinion on Pharmacotherapy 7:6, pages 721-732.
Read now

Articles from other publishers (15)

Christiane Chen-Santel. 2017. Childhood Acute Lymphoblastic Leukemia. Childhood Acute Lymphoblastic Leukemia 201 237 .
Daniel J. DeAngelo. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia 277 296 .
David L. Porter, Edwin P. Alyea, Joseph H. Antin, Marcos DeLima, Eli Estey, J.H. Frederik Falkenburg, Nancy Hardy, Nicolaus Kroeger, Jose Leis, John Levine, David G. Maloney, Karl Peggs, Jacob M. Rowe, Alan S. Wayne, Sergio Giralt, Michael R. Bishop & Koen van Besien. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 16:11, pages 1467-1503.
Crossref
Sima Jeha. (2009) New Therapeutic Strategies in Acute Lymphoblastic Leukemia. Seminars in Hematology 46:1, pages 76-88.
Crossref
Daniel J. DeAngelo & Richard M. Stone. (2008) New agents for the treatment of patients with acute lymphoblastic leukemia. Current Hematologic Malignancy Reports 3:3, pages 135-143.
Crossref
Nikhil C. Munshi & Yu-Tzu Tai. 2009. Myeloma Therapy. Myeloma Therapy 167 202 .
Aric Parnes, Carlo Bifulco & Gary J. Vanasse. (2007) A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases. British Journal of Haematology 139:1, pages 164-165.
Crossref
Ching-Hon Pui & Sima Jeha. (2007) New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nature Reviews Drug Discovery 6:2, pages 149-165.
Crossref
Hillard M. Lazarus & Selina Luger. (2007) Which Patients with Adult Acute Lymphoblastic Leukemia Should Undergo a Hematopoietic Stem Cell Transplantation? Case-Based Discussion. Hematology 2007:1, pages 444-452.
Crossref
Scott J. Rodig, Jeremy S. Abramson, Geraldine S. Pinkus, Steven P. Treon, David M. Dorfman, Henry Y. Dong, Margaret A. Shipp & Jeffery L. Kutok. (2006) Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H). Clinical Cancer Research 12:23, pages 7174-7179.
Crossref
Nicola Gökbuget & Dieter Hoelzer. (2006) Novel antibody-based therapy for acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology 19:4, pages 701-713.
Crossref
Raoul Tibes, Michael J. Keating, Alessandra Ferrajoli, William Wierda, Farhad Ravandi, Guillermo Garcia‐Manero, Susan O'Brien, Jorge Cortes, Srdan Verstovsek, Mary L. Browning & Stefan Faderl. (2006) Activity of alemtuzumab in patients with CD52‐positive acute leukemia. Cancer 106:12, pages 2645-2651.
Crossref
Anne L. Angiolillo, J. Whitlock, Z. Chen, M. Krailo & G. Reaman. (2006) Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group Report. Pediatric Blood & Cancer 46:2, pages 193-197.
Crossref
J-P Laporte, F Isnard, L Fouillard, L Garderet & N-C Gorin. (2004) Reply to Piccaluga et al. Leukemia 19:1, pages 136-136.
Crossref
P P Piccaluga, G Martinelli, M Malagola, M Rondoni, F Bonifazi, G Bandini, G Visani & M Baccarani. (2004) Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. Leukemia 19:1, pages 135-135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.